Microbot Medical to present at Roth Conference; full LIBERTY market release on track for April 2026

Microbot Medical Inc.

CEO Harel Gadot to present fireside Q&A at Roth Annual Growth Conference on March 23, 2026 at 4:00 pm PT.
Limited market release of LIBERTY Endovascular Robotic System began in late 2025; full market release targeted at SIR conference in April 2026.
LIBERTY is the only FDA-cleared, single-use, remotely operated robotic system for peripheral endovascular procedures.
Company highlights multi-site customer traction and procedural diversity during limited release phase.

item 7.01 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001493152-26-010446
form_type: 8-K
ticker: MBOT
cik: 0000883975
company_name: Microbot Medical Inc.
filed_at: 2026-03-17T23:59:59+00:00
discovered_at: 2026-05-14T18:02:37.911458+00:00
generated_at: 2026-05-15T11:16:54.251290+00:00
sec_items: ["7.01", "9.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.55
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001493152-26-010446
json_url: https://secwatch.observer/filing/0001493152-26-010446.json
markdown_url: https://secwatch.observer/filing/0001493152-26-010446.md
text_url: https://secwatch.observer/filing/0001493152-26-010446.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226010446/0001493152-26-010446-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/883975/000149315226010446/form8-k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001493152-26-010446

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.